Cargando…
Adverse events of the yellow fever vaccine in chronic urticaria: evaluation of patients treated or not with omalizumab compared to healthy individuals()()
Autores principales: | Almeida, Laura Ramos de, Criado, Roberta Fachini, Criado, Paulo Ricardo, Ensina, Luis Felipe, Abdalla, Beatrice Martinez Zugaib, Quaresma, Juarez Antônio Simões |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Dermatologia
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245712/ https://www.ncbi.nlm.nih.gov/pubmed/34001398 http://dx.doi.org/10.1016/j.abd.2020.09.009 |
Ejemplares similares
-
What lessons can we learn? Clinical and epidemiological retrospective analysis of 267 patients with urticaria in a Brazilian tertiary center()()
por: Criado, Roberta Fachini Jardim, et al.
Publicado: (2021) -
Chronic urticaria in adults: state-of-the-art in the new
millennium()
por: Criado, Paulo Ricardo, et al.
Publicado: (2015) -
Evaluation of serum levels of C-reactive protein, D-Dimer and Autologous Serum Skin Test in patients with Chronic Spontaneous Urticaria in a Brazilian tertiary center : a cross-sectional study()()
por: Criado, Roberta Fachini, et al.
Publicado: (2021) -
Omalizumab for chronic urticaria in Latin America
por: Wilches, Paul, et al.
Publicado: (2016) -
Urticaria and angioedema as possible reactions of omalizumab
por: Ozbagcivan, Ozlem, et al.
Publicado: (2018)